Location History:
- Victoria, AU (2019)
- Fitzroy North, AU (2020 - 2023)
Company Filing History:
Years Active: 2019-2023
Title: Innovations by Steve Dower in Hemophilia Treatment
Introduction
Steve Dower is an accomplished inventor based in Fitzroy North, Australia. He has made significant contributions to the field of medical science, particularly in the treatment of blood coagulation disorders. With a total of four patents to his name, Dower's work focuses on innovative solutions for hemophilia.
Latest Patents
Dower's latest patents include groundbreaking inventions such as truncated von Willebrand Factor polypeptides for treating hemophilia. This invention pertains to a polypeptide that comprises a truncated von Willebrand Factor (VWF) and a half-life extending moiety. It is designed for use in treating blood coagulation disorders by administering the polypeptide to subjects with reduced endogenous Factor VIII (FVIII) levels. The polypeptide is capable of binding to endogenous FVIII, thereby increasing its activity level following administration. Another notable patent is the mutated truncated von Willebrand Factor, which provides a modified polypeptide that binds Factor VIII. This polypeptide includes specific modifications compared to the original sequence, enhancing its effectiveness in treatment.
Career Highlights
Steve Dower is currently associated with CSL Behring Lengnau AG, a company known for its commitment to developing innovative therapies for patients with serious and rare diseases. His work at CSL Behring has allowed him to focus on advancing treatments that can significantly improve the quality of life for individuals suffering from hemophilia.
Collaborations
Dower collaborates with talented professionals in his field, including Michael Wilson and Dallas Hartman. These partnerships enhance the research and development process, leading to more effective solutions for patients.
Conclusion
Steve Dower's contributions to hemophilia treatment through his innovative patents demonstrate his commitment to improving medical science. His work continues to pave the way for advancements in the treatment of blood coagulation disorders.